Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: Sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 118-122

  Van Der Poll, Tom ^b   De Waal Malefyt, René ^b   Coyle, Susette M ^b   Lowry, Stephen F ^a  

^a Department of Obstetrics Gynecology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 2;

ADULT; AGED; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; ENDOTOXEMIA; FEMALE; FOLLOW UP; HOST RESISTANCE; HUMAN; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTECTION; SEPSIS;

EID: 16944363557     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.118     Document Type: Article

References (21)

1. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-4.
2. Hesse DG, Tracey KJ, Fong Y, et al. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988;166: 147-53.
3. 100 septic shock following therapy with antibody to tumor necrosis factor (TNFα). Circ Shock 1990;30:279-92.
4. Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin 1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550-2.
5. Fischer E, Marano MA, van Zee KJ, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992;89:1551-7.
6. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355-7.
7. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, J5 Study Group, Lambert PH. Tumor necrosis factor and interleukin 1 in the serum of children with severe infectious purpura. N Engl J Med 1988;319:397-400.
8. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-8.
9. Lowry SF, Calvano SE, van der Poll T. Measurement of inflammatory mediators in clinical sepsis. In: Sibbald WJ, Vincent JL, eds. Clinical trials for the treatment of sepsis. New York: Springer-Verlag, 1995: 86-105.
10. Sims JE, Giri JG, Dower SK. The two interleukin-1 receptors play different roles in IL-I actions. Clin Immunol Immunopathol 1994;72:9-14.
11. Giri JG, Wells J, Dower SK, et al. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol 1994;153:5802-9.
12. Colotta F, Orlando S, Fadlon EJ, Sozanni S, Matteucci C, Mantovani A. Chemoattractants induce rapid release of the interleukin I type II decoy receptor in human polymorphonuclear cells. J Exp Med 1995;181: 2181-8.
13. de Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries JE. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
14. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205-8.
15. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-50.
16. McKenzie ANJ, Culpepper JA, de Waal Malefyt R, et al. Interleukin-13, a T cell derived cytokine that regulates human monocyte and B cell function. Proc Natl Acad Sci USA 1993;90:3735-9.
17. de Waal Malefyt R, Figdor CG, Huijbens R, et al. Effects of IL-13 on phenotype, Cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993;151:6370-9.
18. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the produc-tion of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J Exp Med 1995; 181:537-46.
19. Marchant A, Deviere J, Byl B, de Groote D, Vincent JL, Goldman M. Interleukin-10 production during septicaemia. Lancet 1994;343:707-8.
20. Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 1995;171:229-32.
21. Goméz-Jiménez J, Martin MC, Sauri R, et al. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 1995;171:472-5.